These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8097170)

  • 41. [Measurement and clinical significance of inspiratory drive efficacy in patients with chronic obstructive pulmonary disease].
    Wang Y; Luo Y; Yuan Y; He T; Zeng J
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Dec; 28(4):434-6. PubMed ID: 10683962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discharge frequencies of parasternal intercostal and scalene motor units during breathing in normal and COPD subjects.
    Gandevia SC; Leeper JB; McKenzie DK; De Troyer A
    Am J Respir Crit Care Med; 1996 Feb; 153(2):622-8. PubMed ID: 8564108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variation in maximum inspiratory and expiratory pressure after application of inspiratory loads in patients with COPD.
    Fiz J; Gallego M; Izquierdo J; Ruiz J; Roig J; Morera J
    Chest; 1990 Mar; 97(3):618-20. PubMed ID: 2306965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term effects of inhaled beta-adrenergic agonist on breathlessness and central inspiratory drive in patients with nonreversible COPD.
    Pino-García JM; García-Río F; Gómez L; Racionero MA; Díaz-Lobato S; Villamor J
    Chest; 1996 Sep; 110(3):637-41. PubMed ID: 8797404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An evaluation of P0.1 measured in mouth and oesophagus, during carbon dioxide rebreathing in COPD.
    Elliott MW; Mulvey DA; Green M; Moxham J
    Eur Respir J; 1993 Jul; 6(7):1055-9. PubMed ID: 8370431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A quantitative study on the effect of breathing exercises in improving respiratory muscle contration].
    Yan Q; Sun Y; Lin J
    Zhonghua Nei Ke Za Zhi; 1996 Apr; 35(4):235-8. PubMed ID: 9387637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
    Chetta A; Garavaldi G; Cuomo A; Gurrieri G; Olivieri D
    Respiration; 1988; 53(4):220-4. PubMed ID: 2902671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of methylphenidatum on inspiratory muscles function in patients with chronic obstructive pulmonary disease and its mechanism].
    Wang Y; Luo Y; Chen W; Yuan Y; He T; Zeng J
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Mar; 28(1):77-80. PubMed ID: 10684069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Measurement of maximal inspiratory flow and forced inspiratory capacity and its clinical application].
    Xiao X; Luo Y; Chen W; Yuan Y; He T; Zeng J
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):79-81. PubMed ID: 9208627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Broxaterol: therapeutic trials and safety profile.
    Ziment I
    Respiration; 1989; 55 Suppl 2():28-40. PubMed ID: 2572038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential respiratory muscle recruitment induced by clonidine in awake goats.
    Hedrick MS; Dwinell MR; Janssen PL; Pizarro J; Bisgard GE
    J Appl Physiol (1985); 1998 Apr; 84(4):1198-207. PubMed ID: 9516185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pattern of respiratory muscle recruitment during pursed-lip breathing.
    Breslin EH
    Chest; 1992 Jan; 101(1):75-8. PubMed ID: 1729114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of ventilatory muscle activity in healthy subjects and COPD patients with negative pressure ventilation.
    Gigliotti F; Duranti R; Fabiani A; Schiavina M; Scano G
    Chest; 1991 May; 99(5):1186-92. PubMed ID: 2019176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of pyracetam on fatigue of inspiratory muscles in cats].
    Vinogradova IA; Shevchenko AI
    Ross Fiziol Zh Im I M Sechenova; 2001 Mar; 87(3):383-9. PubMed ID: 11386163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Broxaterol: pharmacological profile of a unique structural feature.
    Della Bella D
    Respiration; 1989; 55 Suppl 2():10-4. PubMed ID: 2572035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Which pulmonary volume should be used in physiotherapy to obtain higher maximal inspiratory pressure in COPD patients?
    Marinho PE; Berenguer A; Barros A; Silva TN; Galindo Filho VC; De Andrade AD; Campos TF
    Physiother Res Int; 2005; 10(4):182-9. PubMed ID: 16411613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of dopamine on the respiratory system: friend or foe?
    Ciarka A; Vincent JL; van de Borne P
    Pulm Pharmacol Ther; 2007; 20(6):607-15. PubMed ID: 17150392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dynamic properties of respiratory timing following cocaine administration.
    Richard CA; Ni HF; Harper RK; Harper RM
    Pharmacol Biochem Behav; 1991 Aug; 39(4):941-6. PubMed ID: 1763115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improvements in lung and respiratory muscle function following lung volume reduction surgery: smaller may be better, but how long does It last?
    Baydur A
    Chest; 1999 Dec; 116(6):1507-9. PubMed ID: 10593768
    [No Abstract]   [Full Text] [Related]  

  • 60. Mechanical loading and control of breathing in patients with severe chronic obstructive pulmonary disease.
    Duranti R; Misuri G; Gorini M; Goti P; Gigliotti F; Scano G
    Thorax; 1995 Feb; 50(2):127-33. PubMed ID: 7701449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.